Most Cancer Patients Resume Treatment After ICU, But Half Abandon Original Plan
A new systematic review and meta-analysis of 20 studies finds that 61 percent of cancer patients resume some anticancer treatment ...
A new systematic review and meta-analysis of 20 studies finds that 61 percent of cancer patients resume some anticancer treatment ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.